Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,120.00
-60.00 (-0.97%)
At close: Apr 17, 2026

Genesystem Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Operating Revenue
381.361,208897.033,653
Other Revenue
-00-
381.361,208897.033,653
Revenue Growth (YoY)
-68.42%34.64%-75.44%-
Cost of Revenue
2,8463,0282,4832,486
Gross Profit
-2,465-1,820-1,5861,167
Selling, General & Admin
3,6583,8854,1193,855
Research & Development
2,6893,3443,4253,354
Amortization of Goodwill & Intangibles
598.69776.44196.5173.49
Other Operating Expenses
97.6485.5676.672.81
Operating Expenses
7,2258,2967,8987,772
Operating Income
-9,690-10,116-9,484-6,605
Interest Expense
-124.58-136.25-133.61-95.47
Interest & Investment Income
76.06300.54363.75205.31
Earnings From Equity Investments
--882.76-
Currency Exchange Gain (Loss)
-5.7570.2876.04234.36
Other Non Operating Income (Expenses)
8.487.12124.5929.27
EBT Excluding Unusual Items
-9,736-9,874-8,171-6,231
Gain (Loss) on Sale of Investments
94.84194.97258.36-825.27
Gain (Loss) on Sale of Assets
5-0.18--3.14
Asset Writedown
-6,275---
Pretax Income
-15,911-9,679-7,913-7,060
Income Tax Expense
-1,242-150.73146.411,936
Earnings From Continuing Operations
-14,669-9,529-8,059-8,996
Minority Interest in Earnings
2,714613.41143.55-
Net Income
-11,955-8,915-7,915-8,996
Net Income to Common
-11,955-8,915-7,915-8,996
Shares Outstanding (Basic)
7777
Shares Outstanding (Diluted)
7777
Shares Change (YoY)
-0.46%-1.47%0.69%-
EPS (Basic)
-1754.00-1302.00-1139.05-1303.50
EPS (Diluted)
-1754.00-1302.00-1139.05-1303.50
Free Cash Flow
-7,103-7,595-8,174-6,655
Free Cash Flow Per Share
-1042.12-1109.26-1176.31-964.32
Gross Margin
--150.69%-176.81%31.96%
Operating Margin
-2541.03%-837.58%-1057.33%-180.80%
Profit Margin
-3134.97%-738.17%-882.41%-246.26%
Free Cash Flow Margin
-1862.60%-628.89%-911.27%-182.18%
EBITDA
-8,672-8,873-8,939-6,219
EBITDA Margin
----170.23%
D&A For EBITDA
1,0181,242545.39386.3
EBIT
-9,690-10,116-9,484-6,605
EBIT Margin
----180.80%
Advertising Expenses
248.48182.95281.68239.36
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.